trending Market Intelligence /marketintelligence/en/news-insights/trending/cjxusmyv5yeou5-jnb5-2w2 content esgSubNav
In This List

Bionomics CEO appointed Bioasis chair

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Bionomics CEO appointed Bioasis chair

Canadian biopharmaceutical company Bioasis Technologies Inc. appointed Deborah Rathjen to be the chair of its board.

Rathjen takes over from former board chair and CEO Rob Hutchison, who retired Dec. 4, 2017.

Rathjen is the CEO and managing director of Bionomics Ltd.